Viral Toll Like Receptor activation of pulmonary vascular smooth muscle cells results in endothelin-1 generation; relevance to pathogenesis of pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Viral Toll Like Receptor activation of pulmonary vascular smooth muscle cells results in endothelin-1 generation; relevance to pathogenesis of pulmonary arterial hypertension

Published:2012-10 Issue:4 Volume:426 Page:486-491
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

George Peter M.,Badiger Rekha,Shao Dongmin,Edwards Michael R.,Wort Stephen J.,Paul-Clark Mark J.,Mitchell Jane A.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference23 articles.

1. Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation: relevance to pathogenesis of pulmonary hypertension and vascular remodeling;Wort;Am. J. Respir. Cell Mol. Biol.,2001

2. The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension;Shao;Pharmacol. Res.,2011

3. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension;Machado;Hum. Mutat.,2006

4. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension;Humbert;Am. J. Respir. Crit. Care Med.,1995

5. Primary pulmonary hypertension in HIV infection;Speich;Chest,1991

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toll-like receptor 3 involvement in vascular function;European Journal of Pharmacology;2024-09

2. Machine learning-based revelation of GABBR1 and IQGAP2 as candidate biomarkers of pulmonary arterial hypertension and their correlation with immune infiltration;2023-11-01

3. Interleukin-6 and pulmonary hypertension: from physiopathology to therapy;Frontiers in Immunology;2023-06-28

4. Immune Cells in Pulmonary Arterial Hypertension;Heart, Lung and Circulation;2022-07

5. Toll-Like Receptor 3 in Cardiovascular Diseases;Heart, Lung and Circulation;2022-07